To investigate the role of de-oligomerized SP-D in the development of ALI in mice, we i.t. co- treated C57BL/6 mice with both 0.3 mg/kg rSP-D and 5 mg/kg LPS (rSP-D/LPS group) for 2 days. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.